Gene · 3918
Papers2,268
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,268
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Origin, Differentiation, and Functions of Cancer-Associated Fibroblasts in Gastrointestinal Cancer. | Cell Mol Gastroenterol Hepatol | 2023 | 37451403 | PubTator, text mining | PubMed |
| Transcriptional Landscape of 3D vs. 2D Ovarian Cancer Cell Models. | Cancers (Basel) | 2023 | 37444459 | PubTator, text mining | PubMed |
| End-stage kidney disease: a never healing wound leading to another never healing wound, renal cancer. | J Nephrol | 2023 | 37439962 | PubTator, text mining | PubMed |
| Editorial: The immunosuppressive tumor microenvironment and strategies to revert its immune regulatory milieu for cancer immunotherapy. | Front Immunol | 2023 | 37435084 | PubTator, text mining | PubMed |
| Using Proteome Microarray and Gene Expression Omnibus Database to Screen Tumour-Associated Antigens to Construct the Optimal Diagnostic Model of Oesophageal Squamous Cell Carcinoma. | Clin Oncol (R Coll Radiol) | 2023 | 37433700 | PubTator, text mining | PubMed |
| Combinatorial targeting of a specific EMT/MET network by macroH2A variants safeguards mesenchymal identity. | PLoS One | 2023 | 37432970 | PubTator, text mining | PubMed |
| LAMC2 regulates proliferation, migration, and invasion mediated by the Pl3K/AKT/mTOR pathway in oral. | Oncol Res | 2023 | 37415741 | PubTator, text mining | PubMed |
| The emerging roles of long noncoding RNAs in lymphatic vascular development and disease. | Cell Mol Life Sci | 2023 | 37407839 | PubTator, text mining | PubMed |
| Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations. | Cancer Res Commun | 2023 | 37377611 | PubTator, text mining | PubMed |
| Epigenetic and Immunological Features of Bladder Cancer. | Int J Mol Sci | 2023 | 37373000 | PubTator, text mining | PubMed |
| The Way to Malignant Transformation: Can Epigenetic Alterations Be Used to Diagnose Early-Stage Head and Neck Cancer? | Biomedicines | 2023 | 37371812 | PubTator, text mining | PubMed |
| Transcriptomic Analysis Reveals Candidate Ligand-Receptor Pairs and Signaling Networks Mediating Intercellular Communication between Hair Matrix Cells and Dermal Papilla Cells from Cashmere Goats. | Cells | 2023 | 37371115 | PubTator, text mining | PubMed |
| The Emerging Role of Metformin in the Treatment of Hepatocellular Carcinoma: Is There Any Value in Repurposing Metformin for HCC Immunotherapy? | Cancers (Basel) | 2023 | 37370771 | PubTator, text mining | PubMed |
| Chain-specificity of laminin α1-5 LG45 modules in the recognition of carbohydrate-linked receptors and intramolecular binding. | Sci Rep | 2023 | 37369727 | PubTator, text mining | PubMed |
| TRIM29 hypermethylation drives esophageal cancer progression via suppression of ZNF750. | Cell Death Discov | 2023 | 37365152 | PubTator, text mining | PubMed |
| Skin antiaging effects of a multiple mechanisms hyaluronan complex. | Skin Res Technol | 2023 | 37357659 | PubTator, text mining | PubMed |
| Vasculogenic mimicry score identifies the prognosis and immune landscape of lung adenocarcinoma. | Front Genet | 2023 | 37351348 | PubTator, text mining | PubMed |
| Promoted Abutment-Soft Tissue Integration Around Self-Glazed Zirconia Surfaces with Nanotopography Fabricated by Additive 3D Gel Deposition. | Int J Nanomedicine | 2023 | 37333732 | PubTator, text mining | PubMed |
| PLAU and LAMC2 can predict a poor prognosis in patients with HNSCC. | J Cancer | 2023 | 37325056 | PubTator, text mining | PubMed |
| Integrin alpha 6 homozygous splice-site mutation causes a new form of junctional epidermolysis bullosa in Charolais cattle. | Genet Sel Evol | 2023 | 37308849 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3918/papers?page=13